Phio Pharmaceuticals Corp. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
PHIO Nasdaq 2830 phiopharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series - Oct 19th, 2026 7:53 am
Phio Pharmaceuticals Announces Successful Completion of First Commercial-Scale cGMP Batch of PH-762 Drug Substance - Oct 13th, 2026 5:00 am
OTC Markets Group Announces Third Annual Global Markets Forum Presentations Now Available On Demand - Oct 12th, 2026 6:35 am
Phio Pharmaceuticals to Present at The Global Markets Virtual Forum October 8, 2026 - Oct 6th, 2026 5:00 am
OTC Markets Group Announces Agenda for Third Annual Global Markets Forum, October 7th & 8th - Oct 5th, 2026 6:35 am
Phio Pharmaceuticals to Present at the National Investment Banking Association (NIBA) 153rd Conference - Oct 5th, 2026 5:00 am
Phio Pharmaceuticals to Present Clinical Development Update and Upcoming Catalysts at Life Sciences Future 2026 Conference - Sep 23rd, 2026 5:00 am
Phio Announces Key Development Milestone for PH-762 with FDA Submission Supporting Next Stage of Clinical Development in Cutaneous Squamous Cell Carcinoma - Sep 14th, 2026 5:00 am
Phio Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Sep 11th, 2026 7:00 am
Phio Pharmaceuticals Secures U.S. Notice of Allowance for INTASYL Composition Selectively Targeting BRD4 Protein with Compound PH-894 - Aug 11th, 2026 5:00 am
Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update - Aug 6th, 2026 2:05 pm
Correction to Announcement Regarding Phio Pharmaceuticals Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series - Jul 22nd, 2026 10:30 am
Phio Pharmaceuticals Announces Appointment of Dr. R. Todd Plott to the Board of Directors - Jul 21st, 2026 5:00 am
Phio Pharmaceuticals Expands Global Patent Portfolio With New International Patent Milestones - Jul 15th, 2026 9:06 am
Phio Pharmaceuticals Announces Patent Milestone with Multiple Notices of Allowance and Grant Decision - Jul 15th, 2026 5:00 am
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing - Jun 26th, 2026 6:35 am
Phio Pharmaceuticals Announces "How siRNA Therapy can Change the Course of Cancer Treatment" in a Fireside Chat with Force Family Office on Monday, June 29, 2026 - Jun 25th, 2026 5:00 am
Phio Pharmaceuticals Reaches Key Milestone in Advancing Lead Candidate PH-762 - Jun 24th, 2026 5:00 am